Klinikum Ernst von Bergmann gGmbH — Clinical Trial Site

55 Registered trials

30 Currently recruiting

Organisation

Klinikum Ernst von Bergmann gGmbH

Location

Potsdam, Germany

Identifier

ORG-100024629

Address

Charlottenstrasse 72, Noerdliche Innenstadt, 14467, Germany

Departments

Akad. Lehrkrankenhaus der Humboldt-Universität Berlin (Charité) Studiensekretariat Gynäkologie
Brustzentrum
CF-Zentrum Westbrandenburg, Sektion Cystische Fibrose
Clinic for Gastroenterology, Hepatology, Infectious Disease and Rheumatology
Department of Gastroenterology, Hepatology, Infectious Diseases and Rheumatology
Department of Gastroenterology, Infectious Diseases ans Rheumatology
Ernst von Bergmann Klinikum Potsdam
Frauenklinik
Gastroenterologie, Hepatologie, Infektiologie und Rheumatologie
Gastroenterology
Gynäkologie und Geburtshilfe
gynecology
Gynecology and Obstetrics
Haematologie/ Onkologie
Hämatologie, Onkologie und Palliativmedizin
Hämatologie/Onkologie
HNO
Kinder- und Jugendklinik - CF-Zentrum
Klinik f. Gynäkologie und Geburtshilfe
Klinik für Gastroenterologie
Klinik für Gastroenterologie, Hepatologie, Infektiologie und Rheumatologie
Klinik für Gastroentrologie, Hepatologie, Infektiologie und Rheumatologie
Klinik für Gynäkologie und Geburtshilfe
Klinik für Gynekologie und Geburtshilfe
Klinik für Hämatologie Onkologie und Palliativmedizin
Klinik für Hämatologie und Onkologie
Klinik für Hämatologie, Onkologie und Palliativmedizin
Klinik für Hämatologie, Onkologie und Palliativmedizin
Klinik ür Gynäkologie und Geburtshilfe
Klinikum Ernst von Bergman; Klinik für Hämatologie, Onkologie und Palliativmedizin
Medizinische Klinik, Abteilung Strahlentherapie
Mukoviszidosezentrum Potsdam
N.A.
N/A
NA
Neurologie
Neurologie und Klinische Neuropsychologie
Oncology
Onkologie

Clinical trials at this site (55)

Search interface

A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn’s disease Pending

2025-521037-86-00 Immune system diseases 5
A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active ulcerative coliti… Pending

2025-521038-27-00 Immune system diseases 5
A study to measure mirikizumab levels in breast milk of lactating participants receiving mirikizumab therapeutically for an approved indicat… Pending

2025-522362-78-00 severely active ulcerative colitis (US) and CD (Crohn’s 6
A Study of LY4064809 With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) Pending

2025-522791-92-00 Neoplasm Metastasis 5
Safety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis Pending

2025-523400-72-00 Cystic fibrosis 4
Evaluation of Novel Thrombolytic TGD001 in Patients With Acute Ischemic Stroke Recruiting

2025-522455-26-00 Acute Ischemic Stroke 9 2025-12-17
A study to investigate efficacy and safety of brivekimig in participants with Crohn’s disease Recruiting

2024-517016-30-00 Crohn’s disease 4 2025-09-26
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obe… Recruiting

2024-520209-38-00 Obesity or Overweight 5 2025-09-19
The AIRTIVITY TM Study: A study to find out whether BI 1291583 helps people with bronchiectasis Recruiting

2024-518589-29-00 Bronchiectasis 5 2025-08-21
A PHASE 2 STUDY TO RESEARCH THE SAFETY AND EFFICACY OF TRASTUZUMAB DERUXTECAN VERSUS CDK4/6I PLUS ENDOCRINE THERAPY IN ADVANCED BREAST CANCE… Recruiting

2024-512360-55-00 Unresectable locally recurrent or metastatic hormone re 4 2025-06-30
A Study to Assess the Effectiveness and Safety of Induction Therapy with RO7790121 in Participants with Moderately to Severely Active Crohn'… Recruiting

2024-513054-30-00 Moderately to Severely Active Crohn's Disease (CD) 5 2025-04-16
A study investigating the effect of adding revumenib to treatment with venetoclax + azacitidine in patients with acute myeloid leukemia (AML… Recruiting

2024-512733-32-00 Acute Myeloid Leukemia (AML) 5 2025-03-31
Clinical trial that compares MK-2870 with or without pembrolizumab to chemotherapy in people with breast cancer that cannot be surgically re… Recruiting

2023-504918-29-00 Hormone receptor positive breast cancer 5 2024-08-22
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants with Early Breast Cancer (EMBER-4) Recruiting

2022-501007-28-00 Breast Neoplasms 5 2023-04-18
An induction study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn's Disease Recruiting

2025-521036-11-00 Immune system disseases 5 2026-03-23
An induction study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis Recruiting

2025-521035-37-00 Immune system diseases 5 2026-03-02
Patient-Centered Study of T-DXd in Metastatic HER2-Positive Breast Cancer with Real-Life Side Effect Management Recruiting

2025-521805-41-00 Patients with HER2-positive, locally advanced or metast 5 2026-02-18
Efficacy of top-down therapy with mirikizumab versus standard of care with azathioprine in patients with newly diagnosed moderate-to-severe … Recruiting

2025-522585-72-00 ulcerative colitis 6 2025-12-05
TYPER Recruiting

2024-520290-12-00 Hormone receptor–positive (HRpos)/human epidermal growt 6 2025-11-04
A study to investigate the efficacy and safety of SAR444336 in adults with microscopic colitis in clinical remission. Recruiting

2024-519495-83-00 Digestive system diseases 4 2025-10-28
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn’s Disease and Obesity or Overweight:… Recruiting

2024-520210-21-00 Crohn’s Disease 5 2025-09-19
A study to investigate the efficacy and safety of brivekimig in adult participants with ulcerative colitis. Recruiting

2024-515241-41-00 Ulcerative Colitis 4 2025-09-10
ABCSG 63 / ERIKA: Elacestrant and RIbociclib in Ki67-tested endocrine responsive breAst cancer: An open-label, two-arm, randomized, phase I… Recruiting

2023-505758-17-00 endocrine-responsive HER2-negative early breast cancer 4 2025-08-21
A Study to Assess safety and Effectiveness of the Inavolisib Plus a CDK4/6 Inhibitor and Letrozole Versus Placebo Plus a CDK4/6 Inhibitor an… Recruiting

2024-516162-11-00 Endocrine-Sensitive phosphatidylinositol 3-kinase (PIK3 5 2025-07-14